Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy

Pediatric Cardiology
Dorin SumanaruJean Bergounioux

Abstract

The longer survival of patients with Duchenne muscular dystrophy due to advances in clinical care has increased the incidence of Duchenne muscular dystrophy-associated cardiomyopathy, a nearly consistent feature in the third decade of life. A 26-year-old patient with Duchenne muscular dystrophy experienced severe acute heart failure triggered by pneumonia. Levosimendan was effective in improving heart function.

References

Mar 1, 1990·International Journal of Cardiology·G NigroR J Bain
Jul 23, 2002·Lancet·F FollathUNKNOWN Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study
Apr 7, 2005·Intensive Care Medicine·Andrea MorelliPaolo Pietropaoli
Jun 29, 2007·Clinical Pharmacokinetics·Saila AntilaLasse A Lehtonen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

The International Journal of Cardiovascular Imaging
Barbara J M Mulder, Ernst E van der Wall
Developmental Medicine and Child Neurology
Peter Baxter
Nihon rinsho. Japanese journal of clinical medicine
Yasuhiro Takeshima
© 2022 Meta ULC. All rights reserved